Verastem, Inc.

DB:2VSA Stock Report

Market Cap: €377.5m

Verastem Management

Management criteria checks 2/4

Verastem's CEO is Dan Paterson, appointed in Jun 2019, has a tenure of 5.92 years. total yearly compensation is $2.54M, comprised of 25.5% salary and 74.5% bonuses, including company stock and options. directly owns 0.12% of the company’s shares, worth €438.00K. The average tenure of the management team and the board of directors is 1.5 years and 3.7 years respectively.

Key information

Dan Paterson

Chief executive officer

US$2.5m

Total compensation

CEO salary percentage25.54%
CEO tenure5.9yrs
CEO ownership0.1%
Management average tenure1.5yrs
Board average tenure3.7yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Dan Paterson's remuneration changed compared to Verastem's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2025n/an/a

-US$149m

Dec 31 2024US$3mUS$648k

-US$131m

Sep 30 2024n/an/a

-US$93m

Jun 30 2024n/an/a

-US$89m

Mar 31 2024n/an/a

-US$106m

Dec 31 2023US$4mUS$545k

-US$87m

Sep 30 2023n/an/a

-US$77m

Jun 30 2023n/an/a

-US$75m

Mar 31 2023n/an/a

-US$73m

Dec 31 2022US$698kUS$470k

-US$74m

Sep 30 2022n/an/a

-US$73m

Jun 30 2022n/an/a

-US$78m

Mar 31 2022n/an/a

-US$73m

Dec 31 2021US$2mUS$460k

-US$71m

Sep 30 2021n/an/a

-US$75m

Jun 30 2021n/an/a

-US$39m

Mar 31 2021n/an/a

-US$45m

Dec 31 2020US$2mUS$467k

-US$68m

Sep 30 2020n/an/a

-US$87m

Jun 30 2020n/an/a

-US$130m

Mar 31 2020n/an/a

-US$149m

Dec 31 2019US$2mUS$445k

-US$149m

Compensation vs Market: Dan's total compensation ($USD2.54M) is above average for companies of similar size in the German market ($USD871.08K).

Compensation vs Earnings: Dan's compensation has been consistent with company performance over the past year.

CEO

Dan Paterson (63 yo)

5.9yrs
Tenure
US$2,536,767
Compensation

Mr. Daniel W. Paterson, also known as Dan, serves as Chief Executive Officer Verastem, Inc. since August 1, 2023 and is its President of Verastem, Inc. since June 2019. He is Director of Verastem, Inc. sin...

Leadership Team

NamePositionTenureCompensationOwnership
Daniel Paterson
President5.9yrsUS$2.54m0.12%
€ 438.0k
Daniel Calkins
Chief Financial Officer2.6yrsUS$741.01k0.013%
€ 50.7k
Robert Weinberg
Co-Founder & Chair of Scientific Advisory Boardno datano datano data
Michelle Detwiler
Co-Founderno datano datano data
Matthew Ros
Chief Operating Officerless than a yearno datano data
Jonathan Pachter
Chief Scientific Officer9.1yrsUS$319.51kno data
Cathy Carew
Chief Organizational Effectiveness Officerno datano datano data
Nate Sanburn
Chief Business Officer1.3yrsno datano data
Michael Crowther
Chief Commercial & Strategy Officer1.6yrsno datano data
Colleen Mockbee
Global Head of Regulatory Affairs & Development1.3yrsno datano data
John Hayslip
Chief Medical Officer1.1yrsno datano data
1.5yrs
Average Tenure
52.5yo
Average Age

Experienced Management: 2VSA's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Daniel Paterson
President1.8yrsUS$2.54m0.12%
€ 438.0k
Robert Weinberg
Co-Founder & Chair of Scientific Advisory Boardno datano datano data
Mario Sznol
Member of Scientific Advisory Boardno datano datano data
Michael Kauffman
Lead Independent Director12.5yrsUS$236.34k0.012%
€ 46.7k
Paul A. Bunn
Independent Director3.9yrsUS$132.11k0.011%
€ 42.9k
Eric Rowinsky
Independent Director8yrsUS$255.62k0.011%
€ 42.9k
John Johnson
Independent Director5.1yrsUS$141.35k0.011%
€ 42.9k
Robert Gagnon
Director2.4yrsUS$105.18k0.054%
€ 204.7k
Channing Der
Member of Scientific Advisory Board3.2yrsno datano data
Brian Stuglik
Director7.7yrsUS$172.81k0.16%
€ 596.6k
Anil Kapur
Independent Director2.6yrsUS$132.18k0.011%
€ 42.9k
Michelle Robertson
Independent Director3.5yrsUS$137.29k0.011%
€ 42.9k
3.7yrs
Average Tenure
64yo
Average Age

Experienced Board: 2VSA's board of directors are considered experienced (3.7 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/20 06:00
End of Day Share Price 2025/05/20 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Verastem, Inc. is covered by 24 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Matthew CrossAlliance Global Partners
James MolloyAlliance Global Partners
Kalpit PatelB. Riley Securities, Inc.